[
    [
        {
            "time": "2021-04-01",
            "original_text": "复星医药：BioNTech确认“210102”批次疫苗安全性有效性不受影响",
            "features": {
                "keywords": [
                    "复星医药",
                    "BioNTech",
                    "疫苗",
                    "安全性",
                    "有效性"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药：BioNTech确认“210102”批次疫苗安全性有效性不受影响",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-01",
            "original_text": "多家知名医药企业高管离职，市场推动转型，董监高成员变化",
            "features": {
                "keywords": [
                    "医药企业",
                    "高管离职",
                    "市场转型"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "多家知名医药企业高管离职，市场推动转型，董监高成员变化",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-01",
            "original_text": "社保QFII最新调仓！两类资金分歧巨大",
            "features": {
                "keywords": [
                    "社保",
                    "QFII",
                    "调仓",
                    "分歧"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "社保QFII最新调仓！两类资金分歧巨大",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-01",
            "original_text": "复星医药：将继续配合中国香港及澳门政府疫苗接种计划",
            "features": {
                "keywords": [
                    "复星医药",
                    "疫苗接种",
                    "香港",
                    "澳门"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药：将继续配合中国香港及澳门政府疫苗接种计划",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-01",
            "original_text": "东吴证券给予复星医药买入评级，2020年报点评：创新产品加速转化落地，医疗器械板块迎来新机遇",
            "features": {
                "keywords": [
                    "东吴证券",
                    "复星医药",
                    "买入评级",
                    "创新产品",
                    "医疗器械"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "东吴证券给予复星医药买入评级，2020年报点评：创新产品加速转化落地，医疗器械板块迎来新机遇",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-01",
            "original_text": "中航证券给予复星医药买入评级，2020年报点评：研发创新持续兑现，医疗机械业务增长亮眼",
            "features": {
                "keywords": [
                    "中航证券",
                    "复星医药",
                    "买入评级",
                    "研发创新",
                    "医疗机械"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中航证券给予复星医药买入评级，2020年报点评：研发创新持续兑现，医疗机械业务增长亮眼",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]